Fig. 1From: Drug-induced de novo thrombotic microangiopathy diagnosed 2 years after renal transplantation: a case report and literature reviewClinical course of the patient post-kidney transplant. MMF, mycophenolate mofetil; EVR Everolimus, TAC Tacrolimus, CyA Cyclosporine, RBC Red blood cellsBack to article page